Switzerland's competition commission begins a preliminary review of Microsoft's licensing fees after complaints over recent ...
Jan 15 () - Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D;, betting on new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback